| Q53524293 | 18F-DOPA PET/CT and neuroendocrine tumours. |
| Q36461269 | 18F-DOPA PET/CT unravels malignant paraganglioma mimicking temporomandibular joint disorder |
| Q38082417 | 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type |
| Q36535747 | 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI |
| Q53094166 | A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma. |
| Q47233669 | Anatomical and functional imaging of metastatic pheochromocytoma |
| Q37403588 | Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: a case report |
| Q41852652 | Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide |
| Q37740968 | Catecholamine-secreting paragangliomas: recent progress in diagnosis and perioperative management |
| Q37087817 | Clinical features of paraganglioma syndromes |
| Q44647880 | Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component. |
| Q37380079 | Clinically diagnosed glomus vagale tumour treated with external beam radiotherapy: a review of the published reports |
| Q52886146 | Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma. |
| Q37482780 | Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma |
| Q37040004 | Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma |
| Q36477785 | Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty |
| Q36467134 | Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma |
| Q37220182 | Current and future trends in the anatomical and functional imaging of head and neck paragangliomas |
| Q58005428 | Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis |
| Q37987448 | Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis |
| Q36467722 | EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma |
| Q36744866 | Enzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma |
| Q36886361 | Familial carotid body tumours: is there a role for genetic screening? |
| Q36724520 | Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions |
| Q35198539 | Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy |
| Q36621478 | Functional imaging of neuroendocrine tumours with PET. |
| Q57286804 | Glomus tumor in the floor of the mouth: a case report and review of the literature |
| Q84230075 | Glomus tumour: a rare differential diagnosis of bronchial obstruction in a smoker |
| Q38727790 | Head and Neck Paragangliomas: An Update on Evaluation and Management |
| Q84406350 | Head and neck paragangliomas: Report of 175 patients (1989-2010) |
| Q53229343 | Head-to-head comparison between 18F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas. |
| Q36121961 | Imaging of pheochromocytoma and paraganglioma |
| Q53170883 | Improved anatomic visualization of a glomus caroticum tumour within the carotic bifurcation with combined 68Ga-DOTATATE PET/MRI. |
| Q34643210 | Malignant head and neck paragangliomas in SDHB mutation carriers |
| Q46795898 | Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene--a case report |
| Q37313159 | Management of head and neck paragangliomas: review of 120 patients |
| Q37730951 | Molecular imaging of neuroendocrine tumors |
| Q36121952 | Mutations of the SDHB and SDHD genes |
| Q47132367 | Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism |
| Q35926265 | Paragangliomas and paraganglioma syndromes |
| Q45300231 | Paragangliomas in patients with mutations of the SDHD gene |
| Q44969286 | Paragangliomas in the head-/neck region. I: Classification and diagnosis |
| Q80985197 | Paragangliomas of the head and neck |
| Q36121955 | Paragangliomas of the head and neck: diagnosis and treatment |
| Q46188744 | Pheochromocytoma - still a challenge |
| Q35972320 | Pheochromocytoma and paraganglioma: current functional and future molecular imaging |
| Q38233342 | Role of (18) F-FDOPA PET/CT imaging in endocrinology |
| Q86716341 | Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up |
| Q36749391 | Temporal paragangliomas |
| Q38235857 | The evolving role of neurological imaging in neuro-oncology. |
| Q46660401 | The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas |
| Q33736196 | The use of functional imaging in a patient with head and neck paragangliomas |
| Q40477107 | The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators. |
| Q83335150 | [A young patient with paraganglioma syndrome type I. An interdisciplinary challenge] |
| Q46002942 | [Dignity of carotid body tumors. Review of the literature and clinical experiences]. |
| Q79983782 | [Head and neck paragangliomas: revision of 89 cases in 73 patients] |
| Q81952257 | [Significance of emissary veins in surgical treatment of temporal paragangliomas] |